Combretastatin A4 Prodrug (CA4P): Began Phase I trial

OxiGene Inc. (OXGN; SSE:OXGN), Boston, Mass.
Product:

Read the full 75 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE